Higher efficacy of resveratrol against advanced breast cancer organoids: A comparison with that of clinically relevant drugs.

MLA

Ye, Hai‐Shan, et al. “Higher Efficacy of Resveratrol against Advanced Breast Cancer Organoids: A Comparison with That of Clinically Relevant Drugs.” Phytotherapy Research, vol. 36, no. 8, Aug. 2022, pp. 3313–24. EBSCOhost, https://doi.org/10.1002/ptr.7515.

APA

Ye, H., Gao, H., Li, H., Nie, J., Li, T., Lu, M., Wu, M., Liu, J., & Wang, K. (2022). Higher efficacy of resveratrol against advanced breast cancer organoids: A comparison with that of clinically relevant drugs. Phytotherapy Research, 36(8), 3313–3324. https://doi.org/10.1002/ptr.7515

Chicago

Ye, Hai‐Shan, Hong‐Fei Gao, Hong Li, Jun‐Hua Nie, Ting‐Ting Li, Meng‐Di Lu, Mo‐Li Wu, Jia Liu, and Kun Wang. 2022. “Higher Efficacy of Resveratrol against Advanced Breast Cancer Organoids: A Comparison with That of Clinically Relevant Drugs.” Phytotherapy Research 36 (8): 3313–24. doi:10.1002/ptr.7515.